To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Additional recommended knowledge
It possesses in vitro activity against a variety of gram-positive pathogens including MRSA and MRSE. It is a once-weekly, two-dose antibiotic that Pfizer acquired when it bought Vicuron Pharmaceuticals in 2005.
References and notes
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Dalbavancin". A list of authors is available in Wikipedia.|